| Term 
 
        | What diabetic drugs carry the worst risk of hypoglycemia? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What are the names of the common Sulfonylureas |  | Definition 
 
        | Tolbutamide Tolazamide Chlorpropamide Glyburide Glipizide Glimepiride |  | 
        |  | 
        
        | Term 
 
        | What is the mechanism of Sulfonylureas? What is the adverse effect? |  | Definition 
 
        | Reduce K channel conductance-> insulin release Adverse: Hypoglycemia |  | 
        |  | 
        
        | Term 
 
        | What is the mechanism of action of Metformin What is the adverse effect? |  | Definition 
 
        | Decreases Liver gluconeogenesis Increases glucose uptake in the periphery Requires insulin Adverse Anorexia Metallic Taste |  | 
        |  | 
        
        | Term 
 
        | What is the Mechanism of Action of Acarbose What is the major adverse effect? |  | Definition 
 
        | Blocks Alpha-Glucosidase slowing Glucose absorption in the GI Adverse: Fe Malabsorption |  | 
        |  | 
        
        | Term 
 
        | Pioglitazone/ Rosiglitazone mechanism of action What are the adverse effects? |  | Definition 
 
        | Bind PPAR-Gamma receptor to increase the expression of insulin responsive genes Adverse Heart failure Bone Fracture |  | 
        |  | 
        
        | Term 
 
        | What is the mechanism of Repaglinide, Natetaglinide |  | Definition 
 
        | Closes potassium channels like Sulfonylureas Shorter acting than Sulfonylureas-> less hypoglycemia |  | 
        |  | 
        
        | Term 
 
        | What is the mechanism of action of Exenatide |  | Definition 
 
        | Stimulates insulin secretion when blood sugar is high Blocks glucagon release Delays gastric emptying |  | 
        |  | 
        
        | Term 
 
        | What is the mechanism of action of Pramlintide |  | Definition 
 
        | Amylin homolog-> decreased Glucagon   |  | 
        |  | 
        
        | Term 
 
        | What is the mechanism of action of Sitagliptan and what are the side effects |  | Definition 
 
        | Inhibit Dipeptidyl-peptidase 4-> Decreases incretin breakdown(GLP)-> more insulin, less glucagon |  | 
        |  |